Kardigan

IPO

Cardiovascular Drug Development for Heart Health

Public · South San Francisco, United States · Founded 2023 · $554.0M raised

Employees
51–200
Founded
2023
Business Model
B2B
Total Funding
$554.0M
Last Round
$254.0M Series BOct 2025
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Kardigan is a heart health company modernizing cardiovascular drug development with a late-stage pipeline targeting genetic dilated cardiomyopathy, calcific aortic valve stenosis, and acute severe hypertension. Founded in 2023 by MyoKardia veterans, Kardigan integrates AI-driven real-world data from its Prolaio platform to accelerate clinical programs and develop therapies aimed at curing rather than merely managing cardiovascular disease.

Summary

Kardigan is a Biotech company based in South San Francisco, United States, founded in 2023. It has raised $554.0M in total across 2 rounds, most recently a $254.0M Series B round in Oct 2025. Investors include ARCH Venture Partners, Sequoia Heritage and Fidelity Management.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOJun 2026
$400.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Kardigan on Indexed.vc
<a href="https://indexed.vc/companies/kardigan"><img src="https://indexed.vc/api/badge/company/kardigan" alt="Kardigan on Indexed.vc" width="260" height="76" /></a>